Week 12 -CNS Discovery Analysis Flashcards
What is a challenge occuring at BBB
Establishing a conc. gradient (from blood across BBB)
- Blood conc. is limited
- can ↑ GI tract drug conc. by ↑ drug intake
- BUT when drug diffuses from GIT to blood the conc. is ↓ due to constant blood flow (taking drug away)
- DUE to LOW CONC. in BLOOD = gradient from blood to brain is LIMITED
- even if BBB was permeable movement across BBB is limited
- can NOT force drug out of blood + across BBB down conc. gradient
List the 3 ways to overcome drug movement challenges at BBB
- Improve DIFUSSION
- Get TRANSPORTED in
- Get LOCKED in
How can we “improve diffusion”
By altering the following properties:
- logP: 2 – 4
- logD: 2 – 3
- MW: < 450 Da
- pKa: 6 – 10.5
- HBD: < 3
- PSA: < 90 Å2
NOTE: aim for results around these or better
pKa near physiological pH (= will have enough of neutral form to diffuse through and enough of ionised form to remain solid)
- REMEMEBR ONLY NEUTRAL form can DIFFUSE across membrane
HBD - OH and NH groups
- want to reduce the amount of these groups on molecule
How can we get drug “transported in”
Design drugs that looks SIMILAR to natural nutrients the brain needs e.g. amino acids, glucose etc.
- Drug will be transported across BBB into CNS via transporters
- e.g. L-dopa looks like an amino acid (tyrosine/phenylalanine) = hence why its transported into CNS
How can we get drug “locked in”
Give prodrug that can cross BBB BUT when drug enters brain its metabolised into a molecule that can’t diffuse out of brain
e.g. Temozolomide (TMZ)
- prodrug used in brain tumour treatment
Challenegs with measuring drug conc. in brain
Can NOT measure conc. non-destructively (i.e. measuring from brain requires brain to be extracted)
Example:
- Animal (rat) is dosed, killed then brain is extracted
- Brain is homeogenised then added to solution (buffer)
- Solution is mixed + centrifuged
- After centrifuge, solid bits sink to bottom AND we measure the conc. of the supernatant (liquid on top)
= UNETHICAL